mRNA vaccines
During the recent pandemic, mRNA vaccines were the quickest to be approved and showed high efficacy. However there is currently little expertise with this technology within India, and the formulations typically require ultra-low temperature storage. We have been making efforts to develop this technology locally, and apply it to make vaccine formulations to protect against diverse viral pathogens, with a focus on respiratory viruses.